Trinity compound research profile
SLU-PP-332
SLU-PP-332 isn't actually a peptide (a chain of amino acids) at all — it's a small man-made chemical, but it gets grouped with peptides online because...
Research overview
SLU-PP-332 isn't actually a peptide (a chain of amino acids) at all — it's a small man-made chemical, but it gets grouped with peptides online because people take it the same way. It was created by scientists (at Saint Louis University, hence the "SLU" in the name) to switch on a set of proteins in cells called estrogen-related receptors, or ERRs. Despite the name, it has nothing to do with estrogen or hormones in a reproductive sense (Billon et al., ACS Chem Biol 2023).
Mechanism under study
Imagine your muscle cells have tiny power plants called mitochondria that turn food into energy. SLU-PP-332 flips a genetic switch that tells your body to build more of these power plants and run them harder — kind of like tricking your muscles into thinking you just did a hard workout, even if you didn't. In mouse studies, this made the mice have more endurance, burn more fat, and build more of the muscle fibers used for long-distance activity (Billon 2023).
Human evidence summary
There are none. According to the existing research, no human studies of any kind have been done on SLU-PP-332 — everything known so far comes from lab and animal experiments. Any claims about how it affects humans are guesses based on the mouse data, not proof.
Preclinical evidence summary
In mice that were overweight or obese, SLU-PP-332 helped them burn more energy, break down fat for fuel, lose fat mass, and become better at managing blood sugar (J Pharmacol Exp Ther 2024). The scientists who first made the compound described it as a good "tool" for lab research, not something ready to be a medicine — and they mentioned they have a financial stake in a company working on similar drugs, which is worth knowing when weighing how excited to be about the results (Billon 2023).
Source material
Use the linked publications and records to evaluate study design, population, limitations, and relevance.